Tilray Brands, Inc. (TLRY)
Automate Your Wheel Strategy on TLRY
With Tiblio's Option Bot, you can configure your own wheel strategy including TLRY - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol TLRY
- Rev/Share 9.8033
- Book/Share 0.0
- PB 0.0
- Debt/Equity 0.0
- CurrentRatio 0.0
- ROIC 0.0
- MktCap 1032898342.0
- FreeCF/Share -0.5797
- PFCF -16.1489
- PE -0.3524
- Debt/Assets 0.0
- DivYield 0
- ROE -1.5511
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 4
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Trump Lights Up the Cannabis Market With Plans for Reclassification
Published: December 12, 2025 by: 24/7 Wall Street
Sentiment: Positive
Trump plans to sign an executive order directing federal agencies to reclassify marijuana from Schedule I to Schedule III. Reclassification could boost after-tax profits by 40% to 70% for U.S. cannabis operators by ending the 280E tax penalty.
Read More
Marijuana Stocks Are Soaring Friday on Anticipation Trump Could Soon Make This Change
Published: December 12, 2025 by: Investopedia
Sentiment: Positive
Cannabis stocks surged Friday following reports President Donald Trump could soon reclassify marijuana as a less dangerous substance.
Read More
Trump expected to sign executive order to reclassify marijuana as soon as Monday, source tells CNBC
Published: December 12, 2025 by: CNBC Television
Sentiment: Positive
Cannabis stocks jumped Friday as the White House moved to significantly ease federal restrictions on marijuana. Brandon Gomez has the latest on the timing of a potential Executive Order and why the industry says it's “more optimistic” this time around.
Read More
Tilray Stock Soars on Reclassification Buzz
Published: December 12, 2025 by: Schaeffers Research
Sentiment: Positive
Tilray Brands Inc (NASDAQ:TLRY) stock is soaring today, after the Washington Post reported that U.S. President Donald Trump plans to reclassify marijuana and dramatically loosen restrictions.
Read More
Cannabis stocks rise on reports Trump may reschedule marijuana
Published: December 12, 2025 by: Proactive Investors
Sentiment: Positive
Cannabis stocks surged on Friday on reports that President Donald Trump is considering an executive order to reschedule marijuana at the federal level, potentially moving it from Schedule I to Schedule III. According to people familiar with the matter, Trump has discussed the proposal with marijuana industry executives, Health and Human Services Secretary Robert F.
Read More
Tilray and Canopy Growth Stocks Surge on Reports Trump to Loosen Marijuana Restrictions
Published: December 12, 2025 by: Barrons
Sentiment: Positive
The reclassification of the drug would alleviate tax burdens on cannabis companies.
Read More
3 Canadian Marijuana Stocks To Watch In 2026 That Could See A Massive Run
Published: December 10, 2025 by: MarijuanaStocks
Sentiment: Positive
With 2026 showing to be a big year for reform, how will this impact marijuana stocks? Looking back over the years, it is clear that marijuana stocks have seen their best trading when positive news on reform is released. The speculation of what could happen drives the market action up often. If investors feel the reform is important enough, you'll then see some increased buying action.
Read More
TLRY Stock Loses 38% in a Month: Should You Buy the Dip?
Published: December 03, 2025 by: Zacks Investment Research
Sentiment: Negative
Tilray's slump deepens as a tighter U.S. hemp rule and a reverse split stir uncertainty despite gains in global cannabis sales.
Read More
Tilray Plunges Ahead of a 1-for-10 Reverse Stock Split. Here's What You Need to Know
Published: November 28, 2025 by: Investopedia
Sentiment: Negative
Nearly six months ago, Tilray Brands (TLRY) stockholders approved a 1-for-10 reverse stock split. Now the cannabis firm has given a date it will take effect, and shares are tanking.
Read More
Tilray Brands Strengthens Domestic Lead With Strong Q1 Cannabis Growth
Published: November 28, 2025 by: Zacks Investment Research
Sentiment: Positive
TLRY posts a strong quarter as Canadian cannabis revenues grow and market shares climb across key product categories.
Read More
'Green Wednesday': A high holiday for cannabis before Thanksgiving
Published: November 26, 2025 by: CNBC Television
Sentiment: Positive
Cannabis has carved out it's own holiday shopping rush and it's called "Green Wednesday". Behind April 20, the day before Thanksgiving has become the second-biggest day for cannabis sales in the U.S. Brandon Gomez unpacks the new buzzy trend for an age old tradition.
Read More
TLRY vs. CRLBF: Which Cannabis Player Offers Greater Upside?
Published: November 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Tilray Brands' global expansion and strong Canadian momentum spotlight its edge as investors weigh upside against Cresco Labs' slower growth.
Read More
Three Canadian Cannabis Stocks Worth Watching This Week
Published: November 18, 2025 by: MarijuanaStocks
Sentiment: Positive
The U.S. legal cannabis industry is showing strong momentum, and the time may be ripe to scan for promising Canadian-listed stocks. In fact, the U.S. market is projected to reach about US$45 billion in 2025, growing at roughly an 11-12 percent annual rate through the rest of the decade. Meanwhile, public support for reform sits near record levels, and recent headlines highlighted renewed federal attention on descheduling efforts. These developments increased optimism, although uncertainty remains. Consequently, Canadian cannabis companies with U.S. exposure could benefit significantly if policy improves. At the same time, traders should not overlook technical analysis. Reviewing chart …
Read More
Tilray Brands Extends Profit Momentum With Strong Q1 Results
Published: November 18, 2025 by: Zacks Investment Research
Sentiment: Positive
TLRY posts a sharp profitability turnaround in Q1 as cost control, efficiency gains and portfolio optimization boost results.
Read More
Why Tilray Brands, Inc. (TLRY) Dipped More Than Broader Market Today
Published: November 17, 2025 by: Zacks Investment Research
Sentiment: Neutral
Tilray Brands, Inc. (TLRY) reached $1.03 at the closing of the latest trading day, reflecting a -5.09% change compared to its last close.
Read More
Tilray Brands Publishes New Investor Presentation Highlighting Leadership Across Beverage, Cannabis and Wellness Industries, Showcasing Its Global Growth Strategy and Transformation into a Diversified CPG Powerhouse Shaping the Future of Consumer Products
Published: November 17, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray Brands”, “Tilray” or “the Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today announced the release of its updated investor presentation, outlining the Company's strategic growth roadmap, category diversification, and financial performance milestones across its global platform.
Read More
Cannabis Investing Insight: Here Is How To Invest In Marijuana Stocks
Published: November 12, 2025 by: MarijuanaStocks
Sentiment: Positive
Marijuana Stock investors are keeping a close eye on new market opportunities. With constant shifts in the cannabis industry, forecasting more accurate trading is challenging. The way most pot stocks trade is similar to others in the regard that if one company goes up, others may as well. It is the speculation of what may occur in the grey area industry. Legal operators that make up the industry fight to prove to the public the importance and legitimacy of legal cannabis.
Read More
Tilray Brands Condemns Misguided Prohibitionist Measures and Champions Responsible Hemp Regulations that Keep Consumers Safe and Businesses Thriving
Published: November 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray Brands” or “Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage and hemp-wellness industries, today released the following statement regarding the hemp-related provision included in the recent U.S. government funding bill. Tilray Brands stands united with a coalition of responsible operators representing some of the largest companies in the distribution and retail tiers of the alcohol and beverage industries in urging Congress to come together and establish sensible regulations for hemp-derived THC products.
Read More
Cannabis Stock Tilray Brands Skyrockets 94.5%: Time to Buy, Sell or Hold?
Published: November 07, 2025 by: Zacks Investment Research
Sentiment: Positive
TLRY's 94.5% surge, record fiscal Q1 revenues, and expanding medical cannabis footprint fuel optimism amid global challenges.
Read More
Top Canadian Cannabis Stocks to Watch in November 2025
Published: November 04, 2025 by: MarijuanaStocks
Sentiment: Positive
The Canadian cannabis market continues to evolve as global demand expands and U.S. legalization remains a hot topic. Investors are watching closely as several major producers position themselves for renewed growth through product diversification and strategic international expansion. Despite a challenging regulatory and pricing environment, many companies are shifting focus toward profitability, cost reduction, and high-margin opportunities such as medical exports and branded products.
Read More
Tilray Brands (TLRY) Upgraded to Buy: What Does It Mean for the Stock?
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Tilray Brands (TLRY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
Should You Buy TLRY Stock After Encouraging Q1 Results?
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Tilray's return to profitability, stronger cash flow, and expanding global cannabis and beverage operations highlight its renewed growth story.
Read More
Delta, Pepsi, Applied Digital, Levi's, Tilray Brands kick off Q3 earnings season
Published: October 10, 2025 by: Proactive Investors
Sentiment: Neutral
This week marked the start of earnings season with several major companies reporting results, including Delta Air Lines and PepsiCo, while the big banks like JPMorgan Chase, Citigroup, and Wells Fargo are set to report next week. Investors are closely watching these early reports for cues on the broader economic landscape amid ongoing uncertainties.
Read More
Tilray Brands, Inc. (TLRY) Q1 2026 Earnings Call Transcript
Published: October 09, 2025 by: Seeking Alpha
Sentiment: Neutral
Tilray Brands, Inc. (NASDAQ:TLRY ) Q1 2026 Earnings Call October 9, 2025 8:30 AM EDT Company Participants Berrin Noorata - Chief Corporate Affairs Officer Irwin Simon - President, CEO & Chairman Carl Merton - CFO & Principal Accounting Officer Lloyd Brathwaite - Chief Information Officer Blair MacNeil - President of Tilray Canada Conference Call Participants Aaron Grey - Alliance Global Partners, Research Division William Kirk - ROTH Capital Partners, LLC, Research Division Xin Ma - TD Cowen, Research Division Frederico Yokota Gomes - ATB Capital Markets Inc., Research Division Presentation Operator Thank you for joining today's conference call to discuss …
Read More
Tilray: Another Blah Quarter
Published: October 09, 2025 by: Seeking Alpha
Sentiment: Positive
Tilray Brands surged after FQ1 results, but the business shows minimal growth and is no longer focused on key cannabis sales. TLRY's revenue growth was driven mainly by acquisitions and currency gains, not organic expansion, with weak margins and declining beverage sales. The stock's rally is based on U.S. cannabis rescheduling hopes, yet TLRY lacks exposure to the U.S. cannabis market and trades at a high valuation at 36x adj. EBITDA forecasts.
Read More
Q3 Earnings Season Begins On Positive Note
Published: October 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Pre-market earnings are flat-to-down at this hour, following another robust session Wednesday, led by an expanding AI trade and climbing gold values that have brought market indexes up double-digits from April lows. The Dow is -16 points, the S&P 500 +1 and the Nasdaq -4 points.
Read More
Tilray Delivers Q1 Earnings Surprise, Strengthens Balance Sheet With Lower Debt
Published: October 09, 2025 by: Benzinga
Sentiment: Positive
Tilray Brands Inc. (NASDAQ:TLRY) stock is surging on Thursday after the cannabis company reported better-than-expected first-quarter 2026 earnings.
Read More
Tilray Brands stock surges as cannabis company posts Q1 profit
Published: October 09, 2025 by: Proactive Investors
Sentiment: Positive
Tilray Inc (NASDAQ:TLRY) shares climbed 15% to US$1.98 in early trading on Thursday after the cannabis company announced that it swung to an adjusted net profit of $3.9 million for its fiscal first quarter 2025, from loss of $6.1 million during the same period last year. Its net revenue for the quarter rose 5% to $209.5 million, boosted by a 12% year over year increase in Canadian adult-use cannabis sales and 10% growth in international cannabis revenue.
Read More
Tilray Brands, Inc. (TLRY) Reports Break-Even Earnings for Q1
Published: October 09, 2025 by: Zacks Investment Research
Sentiment: Neutral
Tilray Brands, Inc. (TLRY) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.04 per share a year ago.
Read More
TLRY Gears Up to Report Q1 Earnings: Cannabis Recovery in Focus
Published: October 08, 2025 by: Zacks Investment Research
Sentiment: Positive
Tilray Brands' fiscal first-quarter report is likely to highlight international cannabis gains, European expansion and wellness growth.
Read More
About Tilray Brands, Inc. (TLRY)
- IPO Date 2018-07-19
- Website https://www.tilray.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Irwin David Simon
- Employees 2650